NOVO-B.CO vs. JNJ
NOVO-B.CO (Novo Nordisk A/S) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — NOVO-B.CO in Biotechnology, JNJ in Drug Manufacturers - General. Over the past 10 years, NOVO-B.CO returned 17.36%/yr vs 10.17%/yr for JNJ. At a 0.16 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. JNJ - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while JNJ is traded in USD. To make them comparable, the JNJ values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -8.64% return, which is significantly lower than JNJ's 19.58% return. Over the past 10 years, NOVO-B.CO has outperformed JNJ with an annualized return of 17.36%, while JNJ has yielded a comparatively lower 10.17% annualized return.
NOVO-B.CO
- 1D
- 1.66%
- 1M
- -3.99%
- YTD
- -8.64%
- 6M
- -7.47%
- 1Y
- -41.76%
- 3Y*
- 4.58%
- 5Y*
- 20.64%
- 10Y*
- 17.36%
JNJ
- 1D
- 1.17%
- 1M
- 5.91%
- YTD
- 19.58%
- 6M
- 16.90%
- 1Y
- 57.30%
- 3Y*
- 15.25%
- 5Y*
- 12.07%
- 10Y*
- 10.17%
NOVO-B.CO vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -8.64% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | 15.29% | 36.17% | -6.15% | 39.57% |
JNJ Johnson & Johnson | 19.58% | 30.20% | 1.52% | -11.10% | 12.59% | 19.61% | 1.29% | 18.94% | -0.44% | 9.24% |
Correlation
The correlation between NOVO-B.CO and JNJ is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 2007 | 0.16 |
The correlation between NOVO-B.CO and JNJ shifts across timeframes, from -0.00 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. JNJ — Risk / Return Rank
NOVO-B.CO
JNJ
NOVO-B.CO vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOVO-B.CO | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.16 | ||
| Sortino ratioReturn per unit of downside risk | -5.72 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.58 | -0.71 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | 5.02 | -5.80 |
| Martin ratioReturn relative to average drawdown | -1.15 | 15.94 | -17.09 |
Loading charts...
Drawdowns
NOVO-B.CO vs. JNJ - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, which is greater than JNJ's maximum drawdown of -27.19%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and JNJ.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -27.19% | -49.56% |
Max Drawdown (1Y)Largest decline over 1 year | -54.63% | -11.65% | -42.98% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -18.03% | -58.72% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -20.67% | -56.08% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | -25.55% | -51.20% |
Current DrawdownCurrent decline from peak | -70.15% | -1.45% | -68.70% |
Average DrawdownAverage peak-to-trough decline | -11.29% | -7.00% | -4.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.11% | 3.66% | +33.45% |
Volatility
NOVO-B.CO vs. JNJ - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.47% compared to Johnson & Johnson (JNJ) at 5.79%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.47% | 5.79% | +5.68% |
Volatility (6M)Calculated over the trailing 6-month period | 39.57% | 12.87% | +26.70% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.40% | 17.29% | +37.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.56% | 17.66% | +40.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.08% | 19.38% | +25.70% |
Dividends
NOVO-B.CO vs. JNJ - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 4.07%, more than JNJ's 2.18% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
NOVO-B.CO Novo Nordisk A/S | 4.07% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
NOVO-B.CO vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NOVO-B.CO and JNJ have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer